20Holders
0.16%Avg. Weight
$2.7BTotal Value
0New Buys
Price Chart
NVO
NVOLoading...
Smart Money Score
Holders (20)
13F · by weightRelated Articles (4)
Eli Lilly's Next-Gen Obesity Drug Retatrutide Already Circulating in Gray Market Before FDA ApprovalUS Stocks · 5/8/2026
Pfizer Acquires Obesity Biotech Metsera, Enters GLP-1 War as Trump Medicare Coverage LaunchesUS Stocks · 5/6/2026
Lilly and Novo Nordisk Locked In as Beneficiaries — Medicare to Cover GLP-1 Obesity Drugs for the First Time in July · 5/3/2026
Eli Lilly Reports Apr 30, Novo Nordisk May 6 — A Pivotal Quarter for Obesity Drug Dominance · 4/24/2026